Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 18, 2016 – Ani Pharmaceuticals launched an AB-rated generic version of Concordia’s Nilandron (nilutamide) 150 mg oral tablets.
Download PDF
Return to publications
